The Middle East & Africa radiation oncology market was valued at US$ 172.24 million in 2023 and is expected to reach US$ 304.71 million by 2031; it is estimated to record a CAGR of 7.4% from 2023 to 2031.
Technological Advancement in Radiation Oncology Bolsters Middle East & Africa Radiation Oncology Market
Radiotherapy focuses on destroying the cancerous cells maximum sparing of healthy cells which was achieved over the period of time owing to the advancement in imaging technology such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and others. These imaging technologies helps in identifying the tumors cells along with its exact position and size which led to the development of 3D conformal radiotherapy. Over the period of time, there is constant development in radiotherapy technologies as mentioned below
Flash Therapy: It is being discussed among healthcare professionals, rather than days or weeks the entire dose of massive radiation is delivered at once very quickly. The healthy cells recover well over the period of time and killing only cancer cells. It is under study and if it proves to be safe and effective it can be revolutionary radiation therapy in coming years.
Image-guided radiation therapy (IGRT): This technology allows for real-time imaging of the tumor and surrounding healthy tissue before each treatment session, ensuring that the radiation beams are accurately targeted at the tumor and minimizing damage to nearby organs.
Intensity-modulated radiation therapy (IMRT): IMRT allows for the delivery of varying intensities of radiation to different parts of the tumor, allowing for better dose distribution and sparing of healthy tissue.
Stereotactic body radiation therapy (SBRT): This technology delivers high doses of radiation to small, well-defined tumors in a limited number of treatment sessions, leading to better local control of the tumor.
Proton therapy: Proton therapy uses protons instead of traditional X-rays to deliver radiation to the tumor, allowing for more precise targeting of the tumor and sparing of healthy tissue.
Adaptive radiation therapy: This technology allows for adjustments to the treatment plan based on changes in the tumor size or position during the course of treatment, ensuring that the radiation dose is always optimized for maximum effectiveness.
Moreover, increasing integration of artificial intelligence (AI) in cancer treatment for treatment planning, labelling anatomy patient CT scan images, and others. AI will help to cater to the patient's requirements instantly by offering required solutions during the course of treatment. Additionally, various radiation therapy equipment is integrated with AI which will benefit the patient and healthcare professional both. For Instance, In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments. Therefore, development in radiotherapy technologies and increasing integration of artificial intelligence is expected to expedite the radiation oncology market growth in coming years.
Middle East & Africa Radiation Oncology Market Overview
Over the past 50 years, Saudi Arabia has pioneered cancer care services in the Gulf region through several significant accomplishments. Progress in various cancer treatment areas aligns with its Vision 2030. Currently, Saudi Arabia has ~60 licensed radiation oncologists or clinical oncologists for treating patients with radiation therapy. The Saudi Proton Therapy Center at King Fahad Medical City in Riyadh became the first proton therapy facility in the Kingdom and the Arab world. The Saudi Fund for Development (SFD) opened the Saudi Radiotherapy Center for Cancer Patients at King Abdullah University Hospital in the northern Jordanian city of Ar-Ramtha in July 2021. This center helps over 1,200 cancer patients every year by providing essential services and enhancing healthcare in the northern part of Jordan.
Middle East & Africa Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)
Get more information on this report
Middle East & Africa Radiation Oncology Strategic Insights
Strategic insights for the Middle East & Africa Radiation Oncology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Get more information on this report
Middle East & Africa Radiation Oncology Report Scope
Report Attribute
Details
Market size in 2023
US$ 172.24 Million
Market Size by 2031
US$ 304.71 Million
Global CAGR (2023 - 2031)
7.4%
Historical Data
2021-2022
Forecast period
2024-2031
Segments Covered
By Types
External Beam Radiation Therapy
Internal Beam Radiation Therapy
By Application
Breast Cancer
Prostate Cancer
Lung Cancer
Head & Neck Cancer
Cervical Cancer
Regions and Countries Covered
Middle East and Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
Market leaders and key company profiles
Varian Medical Systems Inc.
Elekta AB.
Accuray Incorporated
IBA Worldwide (Ion Beam Applications SA).
Becton Dickinson and Co.
Perspective Therapeutics Inc
Nordion
Mevion Medical Systems
NTP RADIOISOTOPES.
Mallinckrodt Plc.
Get more information on this report
Middle East & Africa Radiation Oncology Regional Insights
The geographic scope of the Middle East & Africa Radiation Oncology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report
Middle East & Africa Radiation Oncology Market Segmentation
Based on types, the Middle East & Africa radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.
In terms of application, the Middle East & Africa radiation oncology market is segmented into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.
By country, the Middle East & Africa radiation oncology market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa radiation oncology market share in 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, Panacea Medical Technologies Pvt. Ltd, and Curium are some of the leading companies operating in the Middle East & Africa radiation oncology market.
Identical Market Reports with other Region/Countries
The List of Companies - Middle East & Africa Radiation Oncology Market
Varian Medical Systems Inc.
Elekta AB.
Accuray Incorporated
IBA Worldwide (Ion Beam Applications SA).
Becton Dickinson and Co.
Perspective Therapeutics Inc
Nordion
Mevion Medical Systems
NTP RADIOISOTOPES.
Mallinckrodt Plc.
Provision Healthcare
Panacea Medical Technologies Pvt. Ltd
Curium.
Frequently Asked Questions
How big is the Middle East & Africa Radiation Oncology Market?
The Middle East & Africa Radiation Oncology Market is valued at US$ 172.24 Million in 2023, it is projected to reach US$ 304.71 Million by 2031.
What is the CAGR for Middle East & Africa Radiation Oncology Market by (2023 - 2031)?
As per our report Middle East & Africa Radiation Oncology Market, the market size is valued at US$ 172.24 Million in 2023, projecting it to reach US$ 304.71 Million by 2031. This translates to a CAGR of approximately 7.4% during the forecast period.
What segments are covered in this report?
The Middle East & Africa Radiation Oncology Market report typically cover these key segments-
What is the historic period, base year, and forecast period taken for Middle East & Africa Radiation Oncology Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Radiation Oncology Market report:
Historic Period : 2021-2022
Base Year : 2023
Forecast Period : 2024-2031
Who are the major players in Middle East & Africa Radiation Oncology Market?
The Middle East & Africa Radiation Oncology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Varian Medical Systems Inc.
Elekta AB.
Accuray Incorporated
IBA Worldwide (Ion Beam Applications SA).
Becton Dickinson and Co.
Perspective Therapeutics Inc
Nordion
Mevion Medical Systems
NTP RADIOISOTOPES.
Mallinckrodt Plc.
Provision Healthcare
Panacea Medical Technologies Pvt. Ltd
Curium.
Who should buy this report?
The Middle East & Africa Radiation Oncology Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Middle East & Africa Radiation Oncology Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Middle East & Africa Radiation Oncology Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines
Get Free Sample For Middle East & Africa Radiation Oncology Market
